Varicella zoster virus vaccine live - Osaka University/Takeda

Drug Profile

Varicella zoster virus vaccine live - Osaka University/Takeda

Alternative Names: Freeze-dried live attenuated varicella vaccine - Osaka University/Takeda

Latest Information Update: 24 Jan 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Osaka University
  • Class Varicella vaccines; Viruses
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Varicella zoster virus infections

Most Recent Events

  • 14 Jan 2014 Osaka University's live attenuated varicella zoster virus vaccine licensed to Takeda in Japan
  • 31 Dec 1988 Launched for Varicella zoster virus infections (in children, prevention) in Japan (Parenteral)
  • 31 Dec 1974 Clinical trials in Varicella zoster virus infections (in children, prevention) in Japan (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top